Transcript
good morning good morning yes thank you well we were coming to the end of the term rather soon that's sad and what I'd like to do today is picking up on some of the stuff that Bob has been doing begin to show how the things we've learned about understanding molecular biology biochemistry genetics all come together to help us treat disease that is after all the point of all this Bob spoke about this with respect to cancer today my goal is to talk about this with respect to heart disease we've got about 50 minutes or so and I'd like to see if we could solve heart disease by the end of the by the end of the period that seems like a reasonable goal and so I would like you by the end of today's class to design a therapy to to cure most people or at least to prevent a couple million heart attacks all right so that's our goal so we better get to work if we're gonna accomplish that in the allotted time so first off you need to know a little something about heart disease the heart that's obviously an important component of understanding heart disease what's the heart the heart pumps blood and to and from tissues providing nutrients hormones removing waste products cells for example it pumps around red blood cells and white blood cells and things like that and of course oxygen in the blood these are incredibly important things that your heart does if your heart should stop doing it for even relatively brief periods of time it's very bad news all right this is extremely serious not to have your heart pumping as you all know one of the ways in which you run into trouble with your heart pumping is if the vessels that carry blood away from the heart to the periphery arteries become clogged just simple plumbing problem here if they become clogged and the arterial wall gets buildups here we have what is called our Terios sclerosis and it can lead eventually to nearly complete blockade of a vessel and if that vessel for example were to be supplying something important like for example the blood supply to the heart muscles itself that would be extremely bad right because then your heart muscles wouldn't have oxygen and they would quickly die other problems can happen here too where you could have insufficient blood supply to the brain what happens when your brain doesn't get enough oxygen stroke so we have many many of these issues so if it's the brain stroke if the tissue that doesn't get enough oxygen is the heart you get a heart attack and so we want to prevent this process of the vil buildup of plaques in the arteries and these plaques are made up of complex mixtures of proteins lipids and cholesterol and surely by now you all know that cholesterol is this evil molecule and it will indeed be the villain of today's story so that's the basic plan there I'll draw your basic plumbing diagram here just so you have it we've got a heart here this is your heart somewhat simplified picture here the heart pumps blood that goes out to the body to the heart itself to the brain and of course this before it's doing it is receiving oxygenated blood from the lungs so it's really all of these places that we're trying to keep flowing the number of heart attacks deaths from heart attacks and other cardiovascular disease is extraordinarily high it's on the order of 1.5 million deaths per year by contrast number of deaths from cancer it's about 600,000 or so something like that now this has been coming down a little bit for cardiovascular disease partly because of some of the things we'll talk about today but it still is a leading killer of adults in this country and indeed the leading killer of adults in this country although there are projections that cancer may take over in that role a heart disease is incredibly important so if we're gonna try to understand how we're gonna prevent these plaques and I've told you already and you know from the media that these plaques have lots of cholesterol in them and that you all know that high cholesterol is bad how do we know that high cholesterol is bad correlation you know epidemiological correlation is one and as we'll see today there are some other more direct results coming out of genetics that point to this as well what is cholesterol let's talk about cholesterol so this is the structure of cholesterol there we go that's cluster it's a very complex interesting molecule here with lots of rings it is a waxy substance if you were to look at a test tube with a lot of cholesterol in it it would look like wax and it is extremely hydrophobic it will not dissolve in water so if cholesterol is such an evil molecule as you all know from the news media why do we have this evil molecule sorry well because it's absolutely essential for life I mean despite its its rep as an evil molecule it's extraordinarily important the uses of cholesterol are many one you've already said it plays a structural role in cell membranes in the plasma membrane this is not a bit player role in the cell membrane but about half of all the lipids in the cell membrane are cholesterol it's a huge component cholesterol molecules because of their funny shape helps stiffen membranes and strengthen membranes so they strengthen and stiffen the membrane also not only are half of the lipids in your cell membranes cholesterol half of the cholesterol in your body is in the cell membranes so that's the major location of it they're also used these complex molecules as precursors for the synthesis of steroid hormones steroid hormones of course also are evil these days those of you checked the New York Times today saw that Jason Giambi admitted using steroids to a grand jury but steroids are also notwithstanding those kinds of things good for you what are some important steroids in your body's testosterone estrogen glucocorticoids all of these things are made from cholesterol as a precursor and if you look at the structure of steroid hormones you'll recognize that this couple drinks truck sure here is very similar to what's in them and indeed their derivatives from it's also a precursor for the synthesis of vitamin D and it is a precursor for the synthesis of bile acids when your body takes up in when your body takes in triglycerides in the food and your food supply and you need to transport fats like triglycerides across your intestine they need to be emulsified the way that triglycerides are emulsified are with bile acids so you secrete bile acids into your digestive tract it helps emulsify fats and helps you take them up so cholesterol plays a crucial structural role a biochemical role with regard to hormones with regard to vitamin D synthesis and with regard to bile acid synthesis so close rows of good to sing all right now if cholesterol is so extraordinarily hydrophobic how is it that cholesterol gets around the body it's almost entirely nonpolar it doesn't dissolve in water it has one you know little hydroxyl there it's not gonna help a lot yep well by its first thing actually is it's chemically modified to make it a little hydrophilic and then it does bind to hydrophilic proteins and patent particles that help get it around so the first thing that happens to to be able to see you justice store cholesterol in any useful form it's not stored as cholesterol because it's so waxy it would just collapse as a waxy deposit what happens is that it is stored and transported as cholesterol ester a cholesterol ester or seee and it's esterified by adding to it here's my cholesterol again I'll be even less this hydroxyl here is used now for a fatty acid linkage and with this fatty acid attached to the cholesterol you have a cholesterol ester and this is somewhat more soluble all right where do you get your cholesterol from diet to eat cholesterol sorry flutters got close for what else got cholesterol eggs a lot of cholesterol so we eat cholesterol so let's get our sources of cholesterol one diet and sources eggs butter etc what else Yan diet yeah your body actually makes it your own endogenous synthesis so and you would imagine that this is pretty important because cholesterol being half of all plasma membranes you can't just count on cholesterol being sufficiently there in your diet so your body also synthesizes cholesterol the synthesis of cholesterol is a thing of beauty it starts with an incredibly simple molecule acetic acid alright and it goes through many steps and becomes cholesterol which I will summarize here as many steps ok well come back and talk a moment about a few of those steps but it's one of these real triumphs of of biochemistry that people have worked out the whole pathway for cholesterol biosynthesis but it's not I think necessary to remember all of the steps there but it is quite remarkable to go from such an extremely simple molecule like acetic acid all the way to cholesterol and in fact the people worked all this out was a great great achievement alright so those are some of the things you need then carrying on here we've got cholesterol we've got cholesterol coming in by diet we're synthesizing cholesterol we're making cholesterol esters we've got to get them around the body so now we're gonna take these cholesterol esters and we're gonna package them up and send them off so you are saying that proteins would be used hydrophilic proteins might be used and indeed that is the case lipo proteins and lipoprotein particles lipo being fat of course are used to transport cholesterol and actually triglycerides too they are transported in particles that look roughly like this they have a mono layer of phospholipids with some protein stuck in this mono layer of phospholipid and inside is where these cholesterol esters go so we've stuff actually this is where cholesterol is go on esterified so cholesterol goes in here in the cell we want to esterified when it's in the package it sun esterified so we have a mono layer of phospholipids we've got some proteins stuck in that mono layer and it's a very little particle now these particles come in different flavors there are these are very creative names low density lipoprotein particles or LDL there are high density lipoprotein particles HDL and very low-density lipoprotein particles the LDL and some other things called chylomicrons now you can imagine that these names were assigned based on not such so much information just based on density right somebody was purifying lipoprotein particles and said well there's some that are high density low density oh and we've just discovered some very low density ones and this is not a highly informative description of these particles right so people later worked out that these particles were really quite different and particularly the proteins that are in them and those proteins turn out to have important addressing roles in sending these particles to different places the ones that I'll be interested in today are these LR the LDL particles the LDL particles have a particular protein in them that is called a PO protein v100 doesn't matter but that's a particular targeting protein the particular protein there that's in that and these particles are very large they are about two and a half million Dalton's about two hundred and twenty angstroms in size and each of them contains about 1600 cholesterol that's a description of these LDL particles okay so cholesterol if it's gonna be transported in the blood gets packaged up into LDL particles and it gets sent off to cells how does cholesterol get taken up by cells from these LDL particles house itself gonna take up an LDL particle a receptor right it stands to reason that there's going to be a receptor that's going to recognize probably the protein on the surface of this thing that'll recognize that and internalize this particle now this stands to reason to us to you guys because you guys are highly sophisticated about all this but how was it the people came to to know this and to find these receptors well here there's a little bit of an interesting story about how not so long ago when people didn't have you know all the tools of molecular biology and all this and very few of these cellular receptors were known to young medical students began studying a fascinating condition the young medical students were named Joe Goldstein and Mike Brown and in fact at least early in their careers they were working here in Boston so they studied a fascinating condition called familial hypercholesterolemia what is hypercholesterolemia mean cholesterol hyper a lot of cholesterol amia in the blood right so a lot of cholesterol in the blood was this condition and it was characterized as you might guess by the fact that patients had a lot of cholesterol in the blood and that it was familial meaning what it transmitted in families in fact it transmitted in families like a Mendelian trait and it transmitted as an autosomal dominant trait in particular if we looked at most individuals in the population which we'll assume have genotype plus over plus and we look at their cholesterol levels what we find is maybe they have 150 milligrams per deciliter now some people have higher cholesterol than that but I'm gonna take that as an average individuals who by virtue of their genetics appeared to be fh over plus heterozygotes would have cholesterol more like 300 milligrams per deciliter or about double the normal level and individuals who are fh homozygotes fh / fh based on the pedigree analysis here would have greater than 600 milligrams per deciliter in terms of heart attacks normal individuals would have heart attacks at the normal age that doesn't say anything does it because they're normal individuals the age of which they have heart attacks is defined as the normal age but what you'll know that striking is that individuals who are heterozygotes would tend to have heart attacks 10 to 20 years earlier than normal age and individuals who were homozygotes would tend to have heart attacks below the age of 20 so this might be heart attacks when you're 60 this might be hard effects in your 40s and 50s and this might be heart attacks in your 20s or teens so teams in addition some of these individuals have very big cholesterol deposits in their tissues and things like that so this was a very striking phenotype simple Mendelian trait autosomal codominant and to see teenagers or younger kids under the age of 10 with massively occluded vessels and serious heart disease and dying of heart attacks was very striking so Brown and Goldstein decided that if we wanted to understand heart disease in the general population we should understand heart disease in patients with familial hypercholesterolemia particularly the homozygotes now I note that this is about 1 per 1 million individuals and you could make a pretty strong case that Brown and Goldstein are out of their minds trying to study familial hypercholesterolemia at a frequency of 1 in a million and try to imagine that that's going to tell them about heart disease in the general population right and people made that case to them they said what are you doing let's see if this is this is peace squared that means the frequency of the Q squared the allele is one in a thousand and the population right if one in a million people are homozygotes the allele is one in a thousand and so the heterozygote should be about one in 500 well okay so one in 500 is not a terrible you know it's not it's not a small number one in 500 people are heterozygotes for FH that's maybe a little better but still not even a percent it's 1/5 of a percent of the population or heterozygotes for FH it's still something of a gamble to imagine that by studying this relatively rare disease we're gonna learn about stuff in the general population but Brown and Goldstein felt strongly that they would and they did they wanted to know what was the problem with these individuals did they have problems synthesizing their LDL to their problems degrading LDL why was there some why was there so much LDL cholesterol in the blood stream maybe they didn't take up the LDL from the blood stream what was wrong and so they studied just these individuals and what they found to make a interesting and long story short was that when they studied The Binding of radioactive LDL particles to cells from these patients they found that the homozygotes were virtually unable to take up LDL particles there was very low uptake of LDL particles they also found that the heterozygotes had only about half the normal up take of LDL particles what's your hypothesis about what the problem is sorry what's with the uptake and what do you think the genetic basis of this is yep well let's see if there's zero in the homozygotes half the level in the heterozygote could be the receptor and what could be the problem with receptor mutation in the receptor gene what if what if homozygotes for a page had a mutation that abolished the receptor okay that turned out to be the case was that fh was due to mutations in the LDL receptor on cells and indeed until this point the LDL receptor hadn't been characterized on cells but by virtue of brown and goldstein demonstrating that when they did cholesterol LDL radioactive labeled LDL uptake assays and they found that fh homozygotes had no uptake virtually no uptake and that the heterozygotes had half the normal level and that the wild-type individuals plus over plus had the normal level they inferred that the gene product that was mutant in these individuals encoded the LDL receptor and they proceeded to clone this gene product and determined that the gene product encoded a protein that sat on the cell surface it had a cytoplasmic tail it had an extra cellular tail and what it did was it bound to the a PO b100 protein on the LDL particle when it bound the cell made a little pip and in this coated pit that came and internalized the LDL receptor carrying with it the LDL particle and then this then went into the cell the LDL particle was then degraded releasing the cholesterol that could be used by the cell and the receptor itself got recycled back to the surface to work another day and this is quite a general mechanism that is used there by a lot of trafficking receptors like this that grab things from the cell surface bring them into the cell release something into a vesicle and then go back up to the surface there and that the problem was that patients with FH did not have functional LDL receptors now this pointed out LDL receptors were very important here because cells needed to take up cholesterol from the blood stream although they could make some of their own cholesterol but one of the most important places where cholesterol was sequestered and taken up from the blood stream was the liver it turns out that the biggest problem for these patients with familial hypercholesterolemia was that the liver is supposed to be taking up large amounts of LDL to clear the blood stream and keep the levels of LDL at the desirable amount so the liver normally is responsible for taking up clearing about 75% of LDL from the blood if someone has and other cells are responsible for the rest non liver cells take up about 25% of the LDL suppose somebody has half the level of LDL receptors they will take up half as much of these LDL particles and the average level in the blood will be much higher about two fold higher suppose somebody has no LDL receptors well then the LDL receptor pathway is not going to take up these particles and they're gonna have outrageously high levels of LDL other mechanisms will kick in and slightly prevent it from going to infinity of course because things will you know there are other ways things get cleared out but they have huge levels of LDL because they have no such receptors so this is the major reason that there's so much LDL cholesterol particles in the blood in these patients with FA who are fh homozygotes and then FH heterozygotes have a lot and hmm well what are we going to do about it how do you solve a problem like this the liver is not doing its job now I should note the liver does one other thing the liver not only is the major source of taking up LDL cholesterol but it's the major source of producing LDL cholesterol as well the liver produces I remember every cell is able to synthesize cholesterol but most of the cholesterol in your body is synthesized from the liver and put out and so here we have the liver is a source of cholesterol and it's in this disease not acting as an appropriate sink for cholesterol it ought to be sucking up cholesterol and maintaining a balance of producing cholesterol and soaking it back up there we got a real problem well we need to know one more fact and then we can solve the disease well we're not going to solve the disease bowl do the best we can here so cholesterol synthesis I just want to tell you one more fact about it and then toss you the problem cholesterol synthesis I said was acetate scénic acid goes to stuff and let me tell you just a little bit more about it it goes to acid elko a which goes to H M G Co a which goes to mevalonate which goes on to make cholesterol and that the he committed step of cholesterol synthesis is carried out by an enzyme called hmg-coa reductase okay now you have all the facts we know we've got these particles that contain cholesterol we understand that the liver makes cholesterol puts it in your eyes then you get cholesterol from your diet the liver makes cholesterol it takes up cholesterol we have some problems with its uptake of cholesterol let's get to work in design a therapy how are we going to do this so we've got patients designing a rational therapy okay we've got here's your digestive tract you got some liver here it's gonna take up by means of diet it's going to synthesize cholesterol it's going to use cholesterol to make bile acids those bile acids are gonna help bring back fats because it's going to mull safai the fat since the bile acids get recycled it's going to put out cholesterol to the body and LDL particles are going to get internalized into the liver so we have our LDLs okay so has everybody got the action we take up cholesterol and fats and things like that through our diet we got some cholesterol in our body we synthesize cholesterol from acetic acid we have this pathway here we use cholesterol to make bile acids we we take up cholesterol from the blood stream and all of these things together working as a system control how much cholesterol is in your body and it posts portly how much cholesterol in your bloodstream in the form of LDL particles okay we have a patient maybe it's a patient with FH homozygosity but let's start easier let's start with a patient who's a heterozygote for FH what's our first advice eat well get plenty of exercise this is always good advice so plan one so strategy number one diet dietary reduction of cholesterol intake eat less cholesterol that's a good bit of advice stop eating eggs whatever you know you have a serious condition you're don't eat don't eat too so much butter does it do much to reduce LDL levels it turns out not much why doesn't it do much what if I like reduce dramatically my intake of cholesterol well it only makes about a 10% reduction in LDL levels it's not enough to get close to normal why well it turns out your body number 1 gets more efficient 2 taking up cholesterol from your diet so you have some cholesterol there and if you're eating less it takes up with higher efficiency the cholesterol that's there your body's good at doing things like that it also starts synthesizing cholesterol don't have enough cholesterol will make more cholesterol so the liver will make more cholesterol put cholesterol out into the bloodstream and these guys can't take up the cholesterol with the LDL receptor as well and it clogs it up again so in the end between more efficient diet but more efficient uptake of what is in the diet and greater synthesis we've got a complex human system with feedback and all you've tried to do is affect one variable dietary intake and the system regulates so that you haven't made a very big dent in the problem all right next strategy let's try to deplete some let's try to deplete some cholesterol from the body if we could get some cholesterol out of the body by some pathway we might be able to decrease the overall levels of cholesterol so where do we have access to a cholesterol product here in the digestive system we have bile acids got any ideas of what we could do about the bile acids suppose we could somehow deplete your bio assets while they're in your digestive tract then your body would not be able to recycle those bio acids but would have to make more bile acids and it would be a sink for cholesterol right it would start having to use up more cholesterol to produce enough bile acids because they'd have to use up more cholesterol the liver might have to work harder to get cholesterol it synthesize some cholesterol but it would also probably up regulate its LDL receptors to try to draw in more cholesterol from the blood stream so this was the clever idea let's try to get rid of bile acids or not completely derivative let's try to deplete bile acids therefore the liver is going to not be able to reuse them it's gonna have to make more bile acids it's going to need cholesterol and so it's going to up regulate the gene for LDL receptors and draw in more from the bloodstream it turns out that you can feed people bile acid binding resins it's perfectly fine it's so you know just eat them and you can give people bile acid binding resins so strategy number two and what they will do is then they will in their feces eliminate some fraction of the bile acids and as a result they will be able to get rid of some of their cholesterol and they will be able to decrease their overall cholesterol levels does this work it does and you can get maybe a 20% 25% reduction but what's the problem you can't completely get rid of them right because they're necessary so we'll be able to get rid of some bile acids that's really the problem is see we're sitting here as saying so cleverly we're gonna feed the body less cholesterol we're gonna get rid of we're gonna draw cholesterol out of the body by removing bile acids and force the liver to take up more cholesterol from the blood stream right and hopefully it'll operate the gene and it does up regulate the gene when starved for cholesterol cells up regulate their LDL receptor gene and make more LDL receptors that works but we've forgotten one aspect of the system and that was the liver has another option which was synthesize its own cholesterol so we've got a complex system with multiple feedbacks we've affected it at the level of diet we've affected at the level here of drawing stuff out we've managed to get some upper regulation the L receptor LDL receptor gene but it's not enough because the livers choosing to make more cholesterol through its endogenous synthesis pathway so let's keep going what do you recommend yes oh I like that what do you think will happen then so I won't make as much cholesterol what's the liver gonna have to do then and it will up regulate its LDL receptors to do that take up more cholesterol from the blood stream so now we back the liver into a corner right it needs more cholesterol we're gonna inhibit the synthesis of cholesterol and therefore it's going to go to its second source which is uptake from the blood and it's going to induce more LDL receptor everybody got your plan so let's see strategy would be inhibit cholesterol synthesis this is in addition also inhibit cholesterol synthesis and you wanted to inhibit one of those steps any preference of where you'd like to inhibit the step how about the first committed step of cholesterol synthesis so how about H mg Co a reductase inhibitors well it turns out that people found hmg-coa reductase inhibitors lovastatin the fungal product inhibits hmg-coa reductase and then companies Merck and then many other companies developed all sorts of what are called statin drugs that inhibit that enzyme I would venture to say that a large fraction of your parents take statin drugs to lower cholesterol and this is how it works it inhibits the endogenous synthesis pathway at the step HMG co-reductase and in addition if they do things like take bio acid binding resins and there's some combinations of those things and also control their dietary intake of cholesterol and FH heterozygotes can get a 60% reduction in LDL receptor levels in LDL particles that is mighty good that brings them down to normal yep yeah yep so we're not talking about totally removing it we're talking about decreasing it we're bringing it back down to a normal level now it turns out that the cells out there will up regulate their LDL receptors as well and I haven't focused on that but they're taking care of themselves it turns out you have to worry about all these strategies this is too clever by half because you're gonna mess up things in the peripheral periphery but it turns out this the peripheral cells take care of themselves they'll up regulate their LDL receptors enough to get things in and the big problem is that the livers not doing its job but you have to do the clinical tests to see that that's the case this turns out to be a strategy for FH heterozygotes but I just said that many of your parents take these drugs most of your parents aren't the FH heterozygotes perhaps none of your parents are FH heterozygotes that turned out to be one of the most remarkable outcomes of studying this rare genetic disease was it turned out that this strategy which have been the understanding that had been developed from the succeeding lis rare genetic disease and the strategy that had been developed with an eye toward these FH heterozygotes turns out to also work in normal individuals with high cholesterol not because of a complete mutation in the LDL receptor but because of perhaps other differences genetic differences that are more weaker and in fact tens of millions of people take these therapies that were developed for this very rare situation this is a perfect example of where understanding a rare genetic disease points us to the basis for a physiological pathway and particular all these feedback loops that allow us to do something that helps everybody so this has become a major major therapy who are the only people who don't benefit from this particular therapy of tricking the body and supper regulating the LDL receptors homozygotes because they don't have a gene to be upregulated they don't have a functional gene to be upregulated and so homozygotes needs something else what do they need gene therapy the best idea that people have here since the liver regenerates tremendously would be able to take out some liver cells and back genes for LDL receptors and repopulate a liver with LDL receptor transgenic cells and that would help them anyway this is meant to illustrate the power of rational therapy that understanding things can you imagine trying to do this by hit or miss it was your design knowing the pieces that got us here and this is basically what we're trying to do with all of Medicine is get to the point where we can design things that really do work see you next time